The battle against glioblastoma: Classifying molecular profiles for precision medicine

Glioblastoma multiforme (GBM) stands as a formidable adversary in oncology, characterized by its molecular complexity and relentless progression. Despite advancements, the high degree of tumor heterogeneity and its tendency to evade conventional therapies pose significant clinical challenges.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup